e-Therapeutics expects first Indian launches by 2011
This article was originally published in Scrip
Executive Summary
e-Therapeutics is optimistic about the prospects of its late-stage oral asthma and antidepressant compounds making it to the Indian market by 2011. The two compounds and a third one, a topical antibiotic, are being progressed by the domestic company, Khandelwal Laboratories (KLAB), in India.